Telehealth Startup Executives Charged With Fraud By Zachary Pottle ❘ June 18, 2024 The founder and clinical director of telehealth startup Done Global have both been arrested and charged with fraud over ADHD medications. Read More
FDA Urged To Rescind Approval Of Opioid Addiction Test By Zachary Pottle ❘ April 15, 2024 A recent FDA approval of an opioid use disorder test has sparked criticism among the scientific community. Read More
Insomnia Drug May Help Prevent Opioid Relapse By Jessica Sherer ❘ October 3, 2023 Studies show that insomnia drug Suvorexant may help treat Opioid withdrawal symptoms and relapse by improving sleep quality. Read More
Narcan, Opioid-Overdose Reversal Drug, Hits Shelves Today By Jessica Sherer ❘ September 5, 2023 Narcan, a nasal spray version of the life-saving Opioid overdose medication, Naloxone, is now available over-the-counter in the US. Read More
Biden Administration To Limit Telehealth Prescriptions By Zachary Pottle ❘ March 7, 2023 A new ruling proposed by the DEA last week would require in-patient visits for Adderall and Oxycontin, forgoing Telehealth-only prescriptions. Read More
Walmart Offers $3.1 Billion Opioid Settlement By Carmen McCrackin ❘ December 2, 2022 Following CVS Health and Walgreens Co., Walmart has proposed a $3.1 Billion Opioid settlement to local, state, and tribal governments. Read More
New York To Implement Harm Reduction Vending Machines By Emily Murray ❘ January 20, 2022 This year New York City will begin testing a new public health service throughout the city: harm reduction vending machines Read More
A Vaccine Against Addiction By William Henken ❘ January 12, 2022 One scientist is standing on the shoulders of giants and working to develop a vaccine to beat addiction. It can't come too soon. Read More
Pfizer’s Lyrica Causing Outcry By William Henken ❘ September 30, 2021 Lyrica, an addictive drug manufactured by Pfizer, contributes to breathing difficulty and suicide and is being abused by many. Read More
